Boguszewski MCS, Cardoso-Demartini AA, Boguszewski CL et al (2021) Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice. Pituitary 24(5):810–827. https://doi.org/10.1007/s11102-021-01173-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5(1):75. https://doi.org/10.1038/s41572-019-0125-9

Article  PubMed  Google Scholar 

Zhou Z, Zhang S, Hu F (2021) Endocrine disorder in patients with Craniopharyngioma. Front Neurol 12:737743. https://doi.org/10.3389/fneur.2021.737743

Article  PubMed  PubMed Central  Google Scholar 

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM et al (2018) Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study. Eur J Endocrinol 178(1):93–102. https://doi.org/10.1530/EJE-17-0707

Article  CAS  PubMed  Google Scholar 

Geffner M, Lundberg M, Koltowska-Häggström M et al (2004) Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89(11):5435–5440. https://doi.org/10.1210/jc.2004-0667

Article  CAS  PubMed  Google Scholar 

Swerdlow AJ, Reddingius RE, Higgins CD et al (2000) Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85(12):4444–4449. https://doi.org/10.1210/jcem.85.12.7044

Article  CAS  PubMed  Google Scholar 

Sklar CA, Antal Z, Chemaitilly W et al (2018) Hypothalamic-pituitary and Growth disorders in survivors of Childhood Cancer: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 103(8):2761–2784. https://doi.org/10.1210/jc.2018-01175

Article  PubMed  Google Scholar 

Grimberg A, DiVall SA, Polychronakos C et al (2016) Guidelines for growth hormone and insulin-like Growth Factor-I treatment in children and adolescents: growth hormone Deficiency, Idiopathic Short stature, and primary insulin-like Growth Factor-I Deficiency. Horm Res Paediatr 86(6):361–397. https://doi.org/10.1159/000452150

Article  CAS  PubMed  Google Scholar 

Wilson TA, Rose SR, Cohen P et al (2003) Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 143(4):415–421. https://doi.org/10.1067/s0022-3476(03)00246-4

Article  PubMed  Google Scholar 

van Schaik J, Kormelink E, Kabak E et al (2023) Safety of growth hormone replacement therapy in Childhood-Onset Craniopharyngioma: a systematic review and cohort study. Neuroendocrinology 113(10):987–1007. https://doi.org/10.1159/000531226

Article  CAS  PubMed  Google Scholar 

Alotaibi NM, Noormohamed N, Cote DJ et al (2018) Physiologic growth hormone-replacement therapy and Craniopharyngioma Recurrence in Pediatric patients: a Meta-analysis. World Neurosurg 109:487–496e1. https://doi.org/10.1016/j.wneu.2017.09.164

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557

Article  PubMed  PubMed Central  Google Scholar 

Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183

Article  PubMed  Google Scholar 

Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135

Article  PubMed  PubMed Central  Google Scholar 

Shi J, Luo D, Weng H et al (2020) Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 11(5):641–654. https://doi.org/10.1002/jrsm.1429

Article  PubMed  Google Scholar 

Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919

Article  PubMed  PubMed Central  Google Scholar 

Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL (2018) Long-term effects of growth hormone replacement therapy in childhood-onset Craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). Eur J Endocrinol 179(5):331–341. https://doi.org/10.1530/EJE-18-0505

Article  CAS  PubMed  Google Scholar 

Abalı ZY, Öztürk AP, Baş F et al (2023) Long-term endocrinologic Follow-Up of children with brain tumors and comparison of growth hormone therapy outcomes: a SingleCenter experience. Turk Arch Pediatr 58(3):308–313. https://doi.org/10.5152/TurkArchPediatr.2023.22147

Article  Google Scholar 

Darendeliler F, Karagiannis G, Wilton P et al (2006) Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 95(10):1284–1290. https://doi.org/10.1080/08035250600577889

Article  PubMed  Google Scholar 

Du HZ, Chen K, Zhang LY et al (2023) Blood lipid disorders in Post-operative Craniopharyngioma Children and adolescents and the improvement with recombinant human growth hormone replacement. Diabetes Metab Syndr Obes 16:3075–3084. https://doi.org/10.2147/DMSO.S425399

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Wang X, Zhao Y et al (2022) Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection. Int J Endocrinol 2022:7154907. https://doi.org/10.1155/2022/7154907

Miao Y, Fan K, Peng X et al (2023) Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma. Front Endocrinol (Lausanne) 14:1241145. https://doi.org/10.3389/fendo.2023.1241145

Article  PubMed  Google Scholar 

Quoc AN, Beccaria K, Briceño LG et al (2023) GH and Childhood-onset Craniopharyngioma: when to initiate GH replacement therapy? J Clin Endocrinol Metab 108(8):1929–1936. https://doi.org/10.1210/clinem/dgad079

Article  Google Scholar 

Rohrer TR, Langer T, Grabenbauer GG, Buchfelder M, Glowatzki M, Dörr HG (2010) Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children. J Pediatr Endocrinol Metab 23(9):935–942. https://doi.org/10.1515/jpem.2010.150

Article  CAS  PubMed  Google Scholar 

Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81–86. https://doi.org/10.1210/jc.2003-030442

Article  CAS  PubMed  Google Scholar 

Zucchini S, Di Iorgi N, Pozzobon G et al (2022) Management of childhood-onset Craniopharyngioma in Italy: a Multicenter, 7-Year follow-up study of 145 patients. J Clin Endocrinol Metab 107(3):e1020–e1031. https://doi.org/10.1210/clinem/dgab784

Article  PubMed  Google Scholar 

Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM (2003) Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 88(8):3682–3689. https://doi.org/10.1210/jc.2003-030366

Article  CAS  PubMed  Google Scholar 

Pei LL, Guo Y, Chen H, Zhong LY (2023) Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery. J Pediatr Endocrinol Metab 36(5):484–491. https://doi.org/10.1515/jpem-2022-0605

Article  PubMed  Google Scholar 

Hofmann BM, Hoelsken A, Fahlbusch R, Blümcke I, Buslei R (2010) Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation. Neurosurgery 67(3):617–625. https://doi.org/10.1227/01.NEU.0000372918.68453.5B

Artic